tiprankstipranks
Advertisement

QEFA - ETF AI Analysis

Compare

Top Page

QEFA

SPDR MSCI EAFE StrategicFactors ETF (QEFA)

Rating:65Neutral
Price Target:
QEFA, the SPDR MSCI EAFE StrategicFactors ETF, has a solid overall rating driven mainly by high-quality global leaders like Novartis and AstraZeneca, which show strong financial performance, positive earnings outlooks, and strategic growth initiatives. Other major holdings such as ASML, Nestlé, and Zurich Insurance add to the fund’s strength with robust cash flows, reasonable valuations, and generally supportive technical or earnings trends, though some names like Unilever, Shell, and BHP face short-term bearish or mixed technical signals that slightly weigh on the rating. The main risk factor is the fund’s meaningful exposure to a handful of large non-U.S. companies and sectors, where valuation concerns and periods of weak momentum can create bouts of volatility.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past few months, indicating positive recent momentum.
Global Diversification Across Developed Markets
Holdings spread across countries like Japan, the UK, Switzerland, and several others help reduce the impact of weakness in any single market.
Quality Top Holdings
Several of the largest positions, including ASML, Shell, TotalEnergies, and BHP, have delivered strong year-to-date results that support the fund’s overall performance.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially high but is above the cheapest index ETFs, which slightly reduces net returns over time.
Mixed Performance Among Top Holdings
Some major positions such as Roche, Nestlé, Unilever, and Zurich Insurance have been weak this year, which can drag on overall returns.
Limited U.S. Exposure
With only a small portion invested in U.S. companies, the ETF may lag if U.S. markets outperform other developed regions.

QEFA vs. SPDR S&P 500 ETF (SPY)

QEFA Summary

QEFA is an ETF that follows the MSCI EAFE Factor Mix A-Series Index, investing in large and mid-sized companies in developed markets outside North America, such as Japan, the UK, and Europe. It owns well-known names like Nestlé and ASML, and spreads money across many sectors, including financials, health care, and consumer goods. Someone might invest in QEFA to diversify beyond the U.S. and seek long-term growth from established international companies. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The SPDR MSCI EAFE StrategicFactors ETF (Ticker: QEFA) has an expense ratio of 0.3%, meaning you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to incorporate multiple investment factors like value, low volatility, and quality into its strategy.
What would affect this ETF?The QEFA ETF, which focuses on developed markets outside North America, could benefit from stable economic growth in Europe and Asia, as well as increased demand for high-quality and low-volatility stocks in sectors like healthcare and consumer defensive. However, it may face challenges from rising interest rates, which could pressure financial and real estate sectors, and geopolitical tensions or regulatory changes in its key regions could negatively impact its top holdings and overall performance.

QEFA Top 10 Holdings

QEFA’s story is all about steady international blue chips, with Europe doing most of the talking. ASML has been the star of the show, rising strongly and giving the fund a tech-powered tailwind, while resource giant BHP and energy name TotalEnergies add extra lift from the commodities side. On the flip side, consumer staples like Nestlé and Unilever have been losing steam, quietly dragging on returns, and big insurers such as Zurich look more mixed than exciting. Overall, it’s a diversified developed-markets ex‑North America mix, not overly tied to any single sector or stock.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.52%$27.17M€528.97B111.78%
76
Outperform
Novartis AG2.13%$22.95MCHF215.09B25.30%
80
Outperform
Roche Holding AG1.80%$19.37M$336.41B30.82%
73
Outperform
AstraZeneca1.78%$19.22M$287.95B28.75%
80
Outperform
Nestlé SA1.66%$17.86MCHF204.34B-5.71%
71
Outperform
Shell (UK)1.36%$14.67M£173.50B27.29%
73
Outperform
TotalEnergies SE1.19%$12.78M€167.40B46.46%
78
Outperform
BHP Group Ltd1.11%$11.92MAU$316.58B76.90%
68
Neutral
Unilever1.06%$11.37M£91.12B-20.58%
72
Outperform
Zurich Insurance Group0.97%$10.50MCHF83.20B-0.64%
78
Outperform

QEFA Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
94.46
Positive
100DMA
94.27
Positive
200DMA
90.27
Positive
Market Momentum
MACD
0.41
Positive
RSI
50.96
Neutral
STOCH
18.26
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QEFA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 95.79, equal to the 50-day MA of 94.46, and equal to the 200-day MA of 90.27, indicating a neutral trend. The MACD of 0.41 indicates Positive momentum. The RSI at 50.96 is Neutral, neither overbought nor oversold. The STOCH value of 18.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for QEFA.

QEFA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.14B0.30%
65
Neutral
$9.75B0.28%
67
Neutral
$8.76B0.35%
66
Neutral
$6.50B0.07%
66
Neutral
$5.31B0.20%
61
Neutral
$2.21B0.58%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QEFA
SPDR MSCI EAFE StrategicFactors ETF
95.72
14.43
17.75%
FENI
Fidelity Enhanced International ETF
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
BBIN
JPMorgan BetaBuilders International Equity ETF
EFAV
iShares MSCI EAFE Min Vol Factor ETF
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement